Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

OvaScience brings in $37mm through its Series B venture round; adds $3.6mm

Executive Summary

OvaScience (reproductive medicine) has raised $37mm through its Series B venture round. General Catalyst led (and contributes one board member) and was joined by fellow new backers BBT Capital Management, Cycad Group, Hunt BioVentures, and RA Capital as well as current shareholders Bessemer Venture Partners and Longwood Fund. Leerink Swann was the placement agent.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies